Emma Green

694 total citations
18 papers, 164 citations indexed

About

Emma Green is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Emma Green has authored 18 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Emma Green's work include Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (11 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Emma Green is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Lung Cancer Treatments and Mutations (11 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Emma Green collaborates with scholars based in France, United Kingdom and Canada. Emma Green's co-authors include Godfrey M. Hewitt, Alison K. Surridge, Matthew J. G. Gage, Diana Bell, Joseph L. Tomkins, Nicola Stanhope, P.D. Lewis, Robin Green, Michael D. Kopelman and Karen Howarth and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Emma Green

15 papers receiving 151 citations

Peers

Countries citing papers authored by Emma Green

Since Specialization

Citations

This map shows the geographic impact of Emma Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Green more than expected).

Fields of papers citing papers by Emma Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Green. The network helps show where Emma Green may publish in the future.

Co-authorship network of co-authors of Emma Green

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Green. A scholar is included among the top collaborators of Emma Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Green. Emma Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay 2020 ·PLoS ONE ·Jordi Remón, Aurélie Swalduz, David Planchard, Sandra Ortiz‐Cuaran, Laura Mezquita, Ludovic Lacroix, Cécile Jovelet, Etienne Rouleau, (unknown), (unknown), Clive Morris, Greg Jones, Kelly Mercier, Karen Howarth, Emma Green, M. Pérol, Pierre Saintigny, Benjamin Besse	14
2	Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study. 2020 ·Journal of Clinical Oncology ·Daniel Breadner, Mark Vincent, Rohann Correa, (unknown), Andrew Warner, (unknown), Diane Logan, Michael Sanatani, Jawaid Younus, Brian Yaremko, George Rodrigues, Phillip Blanchette, Joanna Laba, Vasudeva Bhat, Clive Morris, Emma Green, Greg Jones, Alison L. Allan, David A. Palma, Jacques Raphael	2
3	Abstract A52: Role of circulating tumor DNA (ctDNA) from liquid biopsy in early-stage NSCLC resected lung tumor investigation (LIBERTI) 2020 ·Clinical Cancer Research ·Daniel Morgensztern, Emma Green, Jennifer C. King, (unknown), (unknown), (unknown), (unknown), Clive Morris, Ramaswamy Govindan	1
4	Efficacy of tyrosine kinase inhibitors (TKIs) based on the ALK resistance mutations on amplicon-based liquid biopsy in ALK positive non-small cell lung cancer (NSCLC) patients (pts). 2019 ·Journal of Clinical Oncology ·Laura Mezquita, Aurélie Swalduz, Cécile Jovelet, Sandra Ortiz‐Cuaran, David Planchard, Gonzalo Recondo, José Carlos Benítez, Karen Howarth, Clive Morris, Emma Green, Ludovic Lacroix, (unknown), Étienne Rouleau, P. Fournel, Caroline Caramella, Claire Tissot, M. Pérol, Luc Friboulet, Benjamin Besse, Pierre Saintigny	1
5	Abstract 937: Longitudinal circulating-tumor DNA profiling of EGFR-mutated non-small cell lung cancer patients treated with EGFR-tyrosine kinase inhibitors 2018 ·Cancer Research ·Sandra Ortiz‐Cuaran, Aurélie Swalduz, (unknown), (unknown), Séverine Martinez, Gilles Clapisson, Virginie Avrillon, (unknown), L. Falchero, P. Fournel, Emma Green, Clive Morris, M. Pérol, (unknown)	0
6	An amplicon-based liquid biopsy for detecting ALK and ROS1 fusions and resistance mutations in advanced non-small cell lung cancer (NSCLC) patients. 2018 ·Journal of Clinical Oncology ·Laura Mezquita, Cécile Jovelet, Ludovic Lacroix, David Planchard, Gonzalo Recondo, Emma Pailler, Édouard Auclin, Vincent Plagnol, Karen Howarth, Clive Morris, Emma Green, Étienne Rouleau, Claudio Nicotra, Caroline Caramella, Julien Adam, Nathalie Auger, Françoise Farace, Luc Friboulet, Benjamin Besse	0
7	Fusion detection and longitudinal circulating tumor DNA (ctDNA) profiling in ALK+ non-small cell lung cancer (NSCLC) patients. 2018 ·Journal of Clinical Oncology ·Aurélie Swalduz, Sandra Ortiz‐Cuaran, Virginie Avrillon, (unknown), Séverine Martinez, Gilles Clapisson, (unknown), David Pérol, Emma Green, Karen Howarth, (unknown), Clive Morris, M. Pérol, Pierre Saintigny	3
8	P3.02b-102 Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients 2017 ·Journal of Thoracic Oncology ·Jordi Remón, Caroline Caramella, (unknown), Ludovic Lacroix, Andrew Lawson, Sarah Smalley, Karen Howarth, Davina Gale, Nitzan Rosenfeld, Emma Green, Vincent Plagnol, David Planchard, (unknown), (unknown), (unknown), Claudio Nicotra, Jean‐Charles Soria, Benjamin Besse	2
9	Evaluation of liquid biopsies for molecular profiling in patients with advanced non-small cell lung cancer (NSCLC) in the relapse treatment setting. 2017 ·Journal of Clinical Oncology ·Jordi Remón, Benjamin Besse, Ludovic Lacroix, Laura Mezquita, Cécile Jovelet, Karen Howarth, Vincent Plagnol, Clive Morris, Claudio Nicotra, (unknown), Emma Green, Jean‐Charles Soria	1
10	Evaluation of stored liquid biopsies for molecular profiling in patients with non-small cell lung cancer (NSCLC). 2017 ·Journal of Clinical Oncology ·Penelope Ann Bradbury, Keyue Ding, Peter Ellis, Lesley Seymour, (unknown), Greg Jones, Clive Morris, Emma Green, Glenwood D. Goss, Ming‐Sound Tsao, Frances A. Shepherd	1
11	Abstract 2743: Comparison of enhanced Tagged-Amplicon Sequencing and digital PCR for circulating tumor DNA analysis in advanced breast cancer 2017 ·Cancer Research ·Isaac García-Murillas, (unknown), Michael Epstein, Karen Howarth, Andrew Lawson, Sarah Hrebien, Emma Green, Nitzan Rosenfeld, Nicholas C. Turner	1
12	Evaluation of liquid biopsies for molecular profiling in untreated patients with stage III/IV non-small cell lung cancer (NSCLC). 2017 ·Journal of Clinical Oncology ·Benjamin Besse, Jordi Remón, Ludovic Lacroix, Laura Mezquita, Cécile Jovelet, Karen Howarth, Vincent Plagnol, Clive Morris, (unknown), Claudio Nicotra, Emma Green, Jean‐Charles Soria	4
13	Circulating tumor DNA profiling of lung cancer patients treated with EGFR inhibitors. 2017 ·Journal of Clinical Oncology ·Sandra Ortiz‐Cuaran, Aurélie Swalduz, Emma Green, Virginie Avrillon, Michael Epstein, Karen Howarth, (unknown), Clive Morris, M. Pérol, Pierre Saintigny	0
14	Abstract 3639: Analytical performance and validation of an enhanced TAm-Seq circulating tumor DNA sequencing assay 2016 ·Cancer Research ·Davina Gale, Vincent Plagnol, Andrew Lawson, Michelle Pugh, Sarah Smalley, Karen Howarth, Mikidache Madi, (unknown), Vasudev Kumanduri, Kitty Lo, James J. Clark, Emma Green, Nitzan Rosenfeld, Tim Forshew	12
15	Abstract 3192: Liquid biopsies for molecular profiling of mutations in non-small cell lung cancer patients lacking tissue samples 2016 ·Cancer Research ·Jordi Remón, Jean Charles Soria, David Planchard, Cécile Jovelet, (unknown), Ludovic Lacroix, (unknown), Andrew Lawson, Sarah Smalley, (unknown), David Gale, Emma Green, Vincent Plagnol, Nitzan Rosenfeld, (unknown), Nathalie Chaput, Benjamin Besse	3
16	Salivary cortisol monitoring in sheep and cows: evidence for acute activation of the hypothalamo-pituitary-adrenal (HPA) axis using two models of stress 2011 ·(unknown), Emma Green, (unknown), (unknown), Derek Renshaw, Robert C. Fowkes	1
17	Reduced Heterozygosity Depresses Sperm Quality in Wild Rabbits, Oryctolagus cuniculus 2006 ·Current Biology ·Matthew J. G. Gage, Alison K. Surridge, Joseph L. Tomkins, Emma Green, (unknown), Diana Bell, Godfrey M. Hewitt	99
18	The case of the amnesic intelligence officer 1994 ·Psychological Medicine ·Michael D. Kopelman, Robin Green, Emma Green, P.D. Lewis, Nicola Stanhope	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact